10 (Pirfenidone Capsule 1)
Pirfenidone Capsule
Product Images NDC 60219-1642
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 60219-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
10 (Pirfenidone Capsule 2)
This appears to be a chart or table showing percentages of patients experiencing a worsening or improvement in %FVC (forced vital capacity) over a period of 52 weeks, with data from two groups: those receiving Pirenidone (n=278) and those receiving a placebo (n=277). The table also displays the absolute change in %FVC from baseline. However, due to the conversion, some of the characters and values are unreadable or corrupted, making it difficult to interpret the exact results.*
10 (Pirfenidone Capsule 3)
10 (Pirfenidone Capsule 4)
This is a data table indicating the results of a study involving two groups of patients, one receiving a placebo and the other a drug called "Prtendone". The text includes information on the number of patients in each group and their respective risk levels across various weeks. There is no further context available.*
10 (Pirfenidone Capsule 5)
This is a description of a medication called Pirfenidone, which is available in capsule form. It provides the NDC code and dosage instructions. The medication should be stored at a temperature between 20°C to 25°C and is manufactured by Amneal Pharmaceuticals Pvt. Ltd. The medication is distributed by Amneal Pharmaceuticals LLC, Bridgewater. The text also includes the manufacturing license number.*
10 (Pirfenidone Capsule 6)
This is information about Pirfenidone capsules, which is a prescription drug typically used to treat a lung disease called idiopathic pulmonary fibrosis (IPF). The capsules come in a bottle of 270 capsules, with each capsule containing 267 mg of Pirfenidone. The usual dosage is described in the package insert, which also contains administration information. The capsules should be stored at between 20° to 25°C (68° to 77°F) and the bottle should be kept tightly closed. However, excursions are permitted between 15° to 30°C (59° to 86°F) according to USP Controlled Room Temperature. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. located in Ahmedabad, INDIA, while Amneal Pharmaceuticals LLC in Bridgewater, NJ 08807, is the distributor of the capsules.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
